United Therapeutics reported $2.32B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Amarin AMRN:US $ 995.98M 65.47M
Ardelyx ARDX:US $ 186.49M 18.88M
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Baxter International BAX:US $ 8004M 148M
Bayer BAYN:GR 32.45B 3.35B
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Emergent Biosolutions EBS:US $ 1162.1M 19M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Halozyme Therapeutics HALO:US $ 999.75M 58.03M
Insmed INSM:US $ 1.04B 537.19M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
Intra Cellular Therapies ITCI:US $ 601.3M 47.8M
Moderna Inc MRNA:US 10.97B 734M
Omeros OMER:US $ 112.4M 20.08M
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Teva Pharmaceutical TEVA:IT 12.82B 421M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M